Bupropion Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 0591-3543

3 FDA label images from Actavis Pharma, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 0591-3543). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image 1

Image 1
Chemical structure of bupropion hydrochloride, showing its molecular arrangement including a chlorophenyl ring and associated functional groups.*
FDA Label Image

Image 2

Image 2
Label for bupropion hydrochloride extended-release tablets, USP (SR) 150 mg by Actavis Pharma, Inc. The label states the product is a twice-a-day dosage after initial titration and contains 60 film-coated extended-release tablets. It includes warnings about usage with Wellbutrin trademarks and states federal law requires dispensing with the medication guide. Storage instructions and manufacturer/distributor details are also shown.*
FDA Label Image

Image 3

Image 3
Packaging label for BuPROPion HCl Extended-Release Tablets USP (SR) 150 mg Starter Pack by Actavis Pharma, Inc. This label features a red and white color scheme and indicates the product is prescription-only for smoking cessation, containing 1 bottle of 60 tablets. It includes usage instructions, dosing schedule diagrams, and regulatory text including warnings and federal law requirements.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.